Pubic Hair Grooming Linked to Sexually Transmitted Infections
A national survey has found an association between pubic hair grooming and sexually transmitted infections.
University of California San Francisco
Give to UCSF
Displaying 31 - 60 of 70
-
-
Researchers Use CRISPR to Accelerate Search for HIV Cure
Researchers at UCSF and the academically affiliated Gladstone Institutes have used a newly developed gene-editing system to find gene mutations that make human immune cells resistant to HIV infection.
-
HIV Active in Tissues of Patients Who Received Antiretroviral Treatment, Study Shows
UCSF researchers found in autopsy tissue samples of patients treated with antiretrovirals that the virus evolved and migrated among tissues similar to the way it did in patients who had never received antiretroviral treatment.
-
UCSF Center for AIDS Prevention Awarded $8.5M From National Institute of Mental Health
-
Countdown to a Cure: The Effort to Finally Defeat AIDS
Spurred by three decades of momentum and fresh funding, UCSF scientists mount a major effort to finally defeat AIDS.
-
Neurologic Symptoms Common in Early HIV Infection
A team led by researchers from UCSF and Yale has found that half of people newly infected with HIV experience neurologic issues.
-
UCSF Global Food Initiative Fellows Tackle Food Insecurity’s Impact on Infectious Diseases
Three UCSF research fellows are exploring the role food insecurity plays in poor health related to infectious diseases, as part of the University of California Global Food Initiative.
-
Big Ideas in Health and Science for 2016
We asked experts across UCSF to identify what's ahead in how we approach research, what disease areas will see major advances, and where basic science will be translating into real treatments.
-
How an Approach Called ‘Shock and Kill’ Could Cure HIV
HIV can lurk for a lifetime in the body, so to truly cure patients, scientists are trying to find ways to target these HIV reservoirs in a strategy known as “shock and kill.”
-
$20M Grant from amfAR Funds Institute for HIV Cure Research
In a bid to end the worst epidemic in modern times, the Foundation for AIDS Research (amfAR) is funding an ambitious effort based in San Francisco to eliminate the human immunodeficiency virus (HIV) from those who are infected.
-
New Look at PrEP Study Points to Efficacy for Transgender Women
In a new look at the groundbreaking iPrEx trial for people at high risk of HIV infection, UCSF researchers have identified strong evidence of efficacy for transgender women when PrEP is used consistently.
-
Agricultural Intervention Improves HIV Outcomes
A multifaceted farming intervention can reduce food insecurity while improving HIV outcomes in patients in Kenya, according to a randomized, controlled trial led by researchers at UCSF.
-
In CRISPR Advance, Scientists Successfully Edit Human T Cells
In a project spearheaded by investigators at UCSF, scientists have devised a new strategy to precisely modify human T cells using the genome-editing system known as CRISPR/Cas9.
-
UCSF Moves Forward with Plans for New General Hospital Research Facility
Research is a key component of UCSF's work at San Francisco General Hospital, and a new proposed research facility will support breakthroughs there for decades to come.
-
Microclinics Help Keep Kenyan HIV Patients in Care
A team led by researchers from UCSF, Organic Health Response and Microclinic International is reporting results of a study that showed significant benefits of microclinics – an innovative intervention that mobilized rural Kenyan HIV patients’ informal social networks to support their staying in care.
-
Antiretroviral Therapy Benefits HIV-infected Stimulant Users, UCSF Study Shows
New clinical research from UCSF shows that 341 HIV-infected men who reported using stimulants such as methamphetamine or cocaine derived life-saving benefits from being on antiretroviral therapy that were comparable to those of HIV-infected men who do not use stimulants.
-
Tseng Receives Funding to Study HIV/AIDS, Sudden Cardiac Death
Zian H. Tseng, MD, MAS, associate professor of medicine in residence in the Cardiology Division and Cardiac Electrophysiology Service at UC San Francisco, received a four-year $2.14 million grant from the National Institutes of Health (NIH) to expand on his research of people with HIV/AIDS and their increased risk of sudden cardiac death.
-
High Rates of Violence Suffered by Unstably Housed Women in San Francisco
New research from UC San Francisco found that 60 percent of the city’s homeless and unstably housed women who are HIV-infected or at high risk to become infected have endured a recent experience of some form of violence.
-
Two UCSF Faculty Elected to AAAS
A renowned molecular biologist and an internationally acclaimed global health leader from UC San Francisco have been elected as members of the American Academy of Arts and Sciences.
-
Harm-Reduction Program Optimizes HIV/AIDS Prevention, UCSF Study Shows
New research from UCSF and the San Francisco AIDS Foundation has found that clients participating in a harm-reduction substance use treatment program, the Stonewall Project, decrease their use of stimulants, such as methamphetamine, and reduce their sexual risk behavior.
-
Scientists Discover How Key Immune Cells Die During HIV Infection and Identify Potential Drug to Block AIDS
Research led by scientists at the UCSF-affiliated Gladstone Institutes has identified the precise chain of molecular events in the human body that drives the death of most of the immune system’s CD4 T cells as an HIV infection leads to AIDS. Further, they have identified an existing anti-inflammatory drug that in laboratory tests blocks the death of these cells.
-
No Link between HIV-Prevention Pill Truvada and Increased Sexual Risk Behavior, Study Finds
A new study provides further proof that regular use of the the HIV antiretroviral drug Truvada can reduce one’s risk for contracting HIV – without increasing sexual risk behavior.
-
Six UCSF Researchers Win NIH Awards for High-Risk, High-Reward Work
UCSF researchers received six of 78 awards announced this week by the National Institutes of Health for innovative, high-risk, high-reward research.
-
Intestinal Bacteria May Fuel Inflammation and Worsen HIV Disease
A new study by UCSF researchers points to changes in intestinal bacteria as a possible explanation for why successfully treated HIV patients nonetheless experience life-shortening chronic diseases.
-
Researchers Extol Virtues of Team Science in Quest for HIV Cure
Two veteran UCSF doctors who have been battling the AIDS epidemic for decades retraced past efforts and described their ongoing quest for a cure for HIV in the Academic Senate’s Third Annual Faculty Research Lecture.
-
UCSF AIDS Walk Teams to Go for the Gold Again
UC San Francisco, a frequent high-performing team at AIDS Walk San Francisco, will again for the gold – the honor given to the top fundraising organizations participating in the annual event.
-
Starting Antiretroviral Therapy Improves HIV-Infected Africans' Nutrition
Starting HIV-infected patients on antiretroviral therapy reduces food insecurity and improves physical health, thereby contributing to the disruption of a lethal syndemic, UCSF and Massachusetts General Hospital researchers have found in a study focused on sub-Saharan Africa.
-
Research Offers New Hope for HIV/AIDS Patients with Cancer
<p>A proposed new treatment to help HIV/AIDS patients suffering from Kaposi’s sarcoma, the most common form of cancer in people with HIV, is now one step closer to becoming a reality thanks to a program that supports promising early-stage research.</p>
-
Early Treatment May Improve Socioeconomic Conditions for People in Rural Sub-Saharan Africa With HIV
Adults with HIV in rural sub-Saharan Africa who receive antiretroviral drugs early in their infection may reap benefits in their ability to work and their children's ability to stay in school, according to a first-of-its-kind clinical study in Uganda that compared socioeconomic outcomes with CD4+ counts — a standard measure of health status for people with HIV.
-
HIV/AIDS Prevention with Truvada: How Pregnant Women and Others May Benefit
<p>The AIDS drug Truvada, approved this week for prevention of HIV infection in uninfected people at high risk, may benefit many uninfected women whose male partners have HIV, including pregnant women, who may be at higher risk.</p>